NRx Pharmaceuticals Inc. (NASDAQ:NRXP) saw a downside of -5.83% to close Friday at $8.73 after subtracting -$0.54 on the day. The 5-day average trading volume is 1,145,040 shares of the company’s common stock. It has gained $10.64 in the past week and touched a new high 1 time within the past 5 days. An average of 1,363,525 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 3,840,066.
NRXP’s 1-month performance is -45.44% or -$7.27 on its low of $8.61 reached on 10/01/21. The company’s shares have touched a 52-week low of $8.39 and high of $76.99, with the stock’s rally to the 52-week high happening on 02/02/21. YTD, NRXP has lost -64.22% or -$15.67 and has reached a new high 9 times. However, the current price is down -88.66%% from the 52-week high price.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
NRx Pharmaceuticals Inc. (NRXP) has a trailing price-to-earnings (P/E) ratio of 33.74 for the broader industry and 32.48 for the sector, meaning that investors are optimistic about the stock’s future prospects. NRXP stock has a beta of 0.14.
NRx Pharmaceuticals Inc.’s quick ratio for the recent quarter was 0.50, with the current ratio over the same period at 0.50 meaning that NRXP stock is able to fulfill its debt obligations.
The effectiveness of a company’s management is also important for investors when it comes to determining the potential profitability of the investment.
Net income and sales went up compared to those figures reported in the previous quarter. EBITDA for the quarter stood at more than -$17.12 million. NRXP stock balance sheet for the recent quarter shows that total liabilities totaled 35.98 million, with total debt at $0.69 million. Shareholders hold equity totaling $48.6 million
Let’s look briefly at NRx Pharmaceuticals Inc. (NRXP) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 01 October was 29.92% to suggest the stock is trending oversold, with historical volatility in this time period at 65.00%.
The stock’s 5-day moving average is $9.38, reflecting a -7.32% or -$0.69 change from its current price. NRXP is currently trading -46.74% above its 20-day SMA, -65.90% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 and SMA200 by -46.93% and -38.09% respectively.
Stochastic %K and %D was 5.26% and 6.83% and the average true range (ATR) pointed at 0.96. The RSI (14) points at 35.60%, while the 14-day stochastic is at 2.50% with the period’s ATR at 1.20. The stock’s 9-day MACD Oscillator is pointing at -0.54 and -1.05 on the 14-day charts.